Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism

Journal of Applied Physiology

Volumn 104, Issue 2, 2008, Pages 363-370

  Rantzau, C ^b   Christopher, M ^a   Alford, F P ^a  

^a St Vincent's Health ^*

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Dog; Glucose disposal; Glycolytic flux; Hepatic glucose production; Metabolic clearance rate of glucose; Muscle biopsy

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLYCEROL; GLYCOGEN; HEPARIN; INTRALIPID; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOG; ENERGY EXPENDITURE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLYCOLYSIS; MALE; MUSCLE CONTRACTION; MUSCLE EXERCISE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BLOOD GLUCOSE; DOGS; ENERGY METABOLISM; EXERTION; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS; GLUCOSE; GLUCOSE-6-PHOSPHATE; GLYCEROL; GLYCOGEN; HYPOGLYCEMIC AGENTS; INFUSIONS, PARENTERAL; LACTIC ACID; LIVER; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; RIBONUCLEOTIDES; TIME FACTORS;

EID: 38949119767     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00500.2007     Document Type: Article

References (53)

1. Alan N, Saggerson ED. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle. Biochem J 334: 233-241, 1998.
2. Aschenback WG, Hirshman MF, Fujii N, Sakamoto K, Howlett KF, Goodyear LJ. Effects of AICAR treatment on glycogen metabolism in skeletal muscle. Diabetes 51: 567-573, 2002.
3. Bergeron R, Russell RRIII, Young LH, Ren JM, Marcucci M, Lee A, Shulman GI. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol Endocrinol Metab 276: E938-E944, 1999.
4. Beyer A, Kigzerow A, Crute B, Kemp BE, Witters LA, Heilmeyer LMP. Muscle phosphorylase kinase is not a substrate of AMP-activated protein kinase. Biol Chem 381: 457-461, 2000.
5. Camacho RC, Lacy DB, James FD, Donahue EP, Wasserman DH. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside renders glucose output by the liver in dog insensitive to a pharmacological increment in insulin. Am J Physiol Endocrinol Metab 289: E1039-E1043, 2005.
6. Camacho RC, Pencek RR, Lacy DB, James FD, Donahue EP, Wassermann DH. Portal venous 5-aminoimidazole-4-carboxamide-1-β-D- ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output. Diabetes 54: 373-382, 2005.
7. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202-E1206, 2000.
8. Christopher MC, Chen ZP, Rantzau C, Kemp BE, Alford FP. Skeletal muscle basal AMP-activated protein kinase activity is chronically elevated in alloxan-diabetic dogs: impact of exercise. J Appl Physiol 95: 1523-1530, 2003.
9. Christopher MC, Rantzau C, Chen ZP, Snow R, Kemp BE, Alford FP. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion. Am J Physiol Endocrinol Metab 291: E1131-E1140, 2006.
10. Christopher MC, Rantzau C, McConell G, Kemp BE, Alford FP. Prevailing glycemia is critical to the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs. J Appl Physiol 98: 930-939, 2005.
11. Christopher MC, Rantzau C, Ward GM, Alford FP. Impact of variable insulinemia and glycemia on in vivo glycolysis and glucose storage in dogs. Am J Physiol Endocrinol Metab 266: E62-E71, 1994.
12. Corton JM, Gillespie JG, Hawkey SA, Hardie DG. 5-Aminoimidazole-4-carboxamide ribonucleotide: a specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
13. Costill DL, Coyle E, Dalsky G, Evans W, Fink W, Hoopes D. Effects of elevated plasma FFA and insulin on muscle glycogen usage during exercise. J Appl Physiol 43: 695-699, 1977.
14. Dean D, Daugaard JR, Young ME, Saha A, Vavvas D, Asp S, Kiens B, Kim KH, Witters L, Richter EA, Ruderman N. Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 49: 1295-1300, 2000.
15. Del Prato S, Bonadonna RC, Bonora E, Gulli G, Solini A, Shank M, DeFronzo RA. Characterisation of defects of insulin action in Type 2 diabetes mellitus. J Clin Invest 91: 484-494, 1993.
16. Dyck DJ, Bonen A. Muscle contraction increases palmitate esterification and oxidation and triacylglycerol oxidation. Am J Physiol Endocrinol Metab 275: E888-E896, 1998.
17. Dyck DJ, Peters SJ, Wendling PS, Chesley A, Hultman E, Spriet LL. Regulation of muscle glycogen phosphorylase activity during intense aerobic cycling with elevated FFA. Am J Physiol Endocrinol Metab 270: E116-E125, 1996.
18. Fisher SJ, Lekas M, Shi ZQ, Bilinski D, Carvalho G, Giacca A, Vranic M. Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes 46: 1805-1812, 1997.
19. Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, Goodyear LJ. Exercise induces isoform-specific increase in 5′ AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273: 1150-1155, 2000.
20. Hargreaves M, Kiens B, Richter E. Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising man. J Appl Physiol 90: 194-201, 1991.
21. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, Goodyear LJ. Metabolic stress and altered glucose transport. Activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49: 527-531, 2000.
22. Howlett RA, Parolin ML, Dyck DJ, Hultman E, Jones NL, Heigenhauser GFR, Spriet LL. Regulation of skeletal muscle glycogen phosphorylase and pyruvate dehydrogenase at varying power outputs. Am J Physiol Regul Integr Comp Physiol 275: R418-R425, 1998.
23. Kaushik VK, Young ME, Dean DJ, Kurowski TG, Saha AK, Ruderman NB. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 281: E335-E340, 2001.
24. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24: 22-25, 1999.
25. Kelley KM, Hamann J, Navarre C, Gladden LB. Lactate metabolism in resting and contracting canine skeletal muscle with elevated lactate concentration. J Appl Physiol 93: 865-872, 2002.
26. Kurth-Kraswek EJ, Hirshman MF, Goodyear LJ, Winder WW. 5′-AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671, 1999.
27. Longnus SI, Wambolt RB, Parsons HL, Brownsey RW, Allard MF. 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am J Physiol Regul Integr Comp Physiol 284: R936-R944, 2003.
28. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
29. Mu J, Brozinick JT, Valladares O, Bucan M, Birmhaum MJ. A role for AMP-activated protein kinase in contraction and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094, 2001.
30. Muoio DM, Seefeld K, Witters LA, Coleman RA. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338: 783-791, 1999.
31. Odland LM, Heigenhauser GJ, Wong D, Hollidge-Horvat MG, Spriet LL. Effects of increased fat availability on fat-carbohydrate interaction during prolonged exercise in men. Am J Physiol Regul Integr Comp Physiol 274: R894-R902, 1998.
32. Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, Winder WW. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol 92: 2475-2482, 2002.
33. Pencek RR, Shearer J, Comacho RC, James FD, Lacy B, Fueger PT, Donahue EP, Snead W, Wasserman DH. 5-Aminoimidazole-4-carboxamide-1-β- D-ribofuranoside causes acute hepatic insulin resistance in vivo. Diabetes 54: 335-360, 2005.
34. Randle PJ, Garland PB, Hales CN, Newsholm EA. The glucose fatty-acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
35. Raney MA, Yie AJ, Todd MK, Turcotte LP. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low intensity muscle contraction. Am J Physiol Endocrinol Metab 288: E592-E598, 2005.
36. Rasmussen BB, Winder WW. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J Appl Physiol 83: 1104-1109, 1997.
37. Rennie F, Holloszy JO. Inhibition of glucose uptake and glycogen availability by oleate in well oxygenated perfused skeletal muscle. Biochem J 168: 161-170, 1977.
38. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Furnsinn C, Moser E, Waldhausl W. Rapid impairment of skeletal muscle transport/phosphorylation by free fatty acids in humans. Diabetes 48: 358-364, 1999.
39. Romijin JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, Wolf RR. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol Endocrinol Metab 265: E380-E391, 1993.
40. Romijin JA, Coyle EF, Sidossis LS, Zhang XJ, Wolfe RR. Relationship between fatty acid delivering and fatty acid oxidation during strenuous exercise. J Appl Physiol 79: 1939-1945, 1995.
41. Schalin-Jantti C, Harkonen M, Groop LC. Impaired activation of glycogen synthase in people with increased risk for developing NIDDM. Diabetes 41: 598-604, 1992.
42. Shang J, Lehrman MA. Activation of glycogen phosphorylase with 5-amino-imidazole-4-carboxamide riboside (AICAR): assessment of glycogen as a precursor of mannosyl residues in glycoconjugates. J Biol Chem 279: 12076-12080, 2004.
43. Sjogaard G, Adams RP, Saltin B. Water and ion shifts in skeletal muscle of humans with intense dynamic knee extension. Am J Physiol Regul Integr Comp Physiol 248: R190-R196, 1985.
44. Sjogaard G, Saltin B. Extra- and intracellular water spaces in muscle in man at rest and with dynamic exercise. Am J Physiol Regul Integr Comp Physiol 243: R271-R280, 1982.
45. Smith AC, Bruce CR, Dyck DJ. AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting soleus muscle. J Physiol 565: 537-546, 2005.
46. Smith AC, Bruce CR, Dyck DJ. AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle. J Physiol 565: 547-553, 2005.
47. Steel R, Wall JS, de Bodo RC, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
48. Stephens TJ, Chen ZP, Canny BJ, Michell BJ, Kemp BE, McConell GK. Progressive increase in human skeletal muscle AMPK-2 activity and acetyl-CoA carboxylase phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688-E694, 2002.
49. Van Loon LJC, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ. The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536: 295-304, 2001.
50. Wasserman DE, Lickley HLA, Vranic M. Interactions between glucagon and other counterregulatory hormones during normoglycaemic and hypoglycaemic exercise in dogs. J Clin Invest 74: 1404-1413, 1984.
51. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol Endocrinol Metab 277: E1-E10, 1999.
52. Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA, Kiens B. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 528: 221-226, 2000.
53. Woods A, Johnstone SR, Dickenson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13: 2004-2008, 2003.